Ad is loading...
MENU
GLUE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Monte Rosa Therapeutics (GLUE) Ownership - Who owns Monte Rosa Therapeutics?
Profile
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
605.77M
P/E Ratio
N/A
Total Cash
242.19M
Projected Growth
N/A
Total Debt
43.7M
Revenue
14.98M
Risk (Beta)
1.15
Dividend Yield
N/A
Total Cash/Share
3.94
Total Debt/Equity
N/A
Revenue/Share
0.22 USD as % of share price
Fundamentals
GLUE
Capitalization
606M
P/E Ratio
N/A
Risk (Beta)
1.15
Dividend Yield
N/A
Total Cash
242M
Total Cash/Share
3.94
Total Debt
43.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.22%
Revenue
15M
ROE
N/A
Book Value
205M
P/B Ratio
3.06
Cash Flow
N/A
Earnings
-1.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
6.03
Current Revenue Per Employee
89475.73
Dividends Per Share - Security
N/A
EBITDA
-121.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-42.10
Shares Held By Institutions
342M
Shares Outstanding - Current
61.4M
Total Liabilities
110M
Total Volume MTD
N/A
Value
N/A
Gain YTD
74.513
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com